Aug 2026· Frontiers in Immunology· Vol 17· 0 citations· 127 references
Medicine
TL;DR
It is proposed that mitochondrial transfer acts as a tripartite educator during metastasis by driving three coordinated programs: metabolic licensing, immune rewiring, and stromal remodeling.
Abstract
Tumor metastasis is the leading cause of cancer-related deaths. It depends not only on the intrinsic properties of cancer cells but also on their active shaping of the tumor microenvironment. Recent studies have identified mitochondrial transfer(MT) as a key mechanism underlying this tumor–microenvironment crosstalk. Beyond serving as a simple metabolic rescue pathway, MT functions as an intercellular reprogramming process that promotes metastatic progression. In this Review, we propose that MT acts as a tripartite educator during metastasis by driving three coordinated programs: metabolic licensing, immune rewiring, and stromal remodeling. Metabolic licensing enhances the survival and invasive capacity of cancer cells. Immune rewiring helps tumor cells evade immune surveillance. Stromal remodeling reprograms the tumor microenvironment into a permissive niche that supports tumor establishment. We summarize current evidence supporting each of these three programs and discuss emerging therapeutic strategies aimed at either blocking pathological MT or exploiting it for antitumor intervention.
Symbiotic interactions between tumor cells and immune cells are key drivers of tumor progression and treatment resistance. Extracellular vesicles (EVs) are key mediators of intercellular crosstalk within the tumor microenvironment. An increasing number of studies have demonstrated that EVs play a significant role in re...
Jin-Peng Wang, Zhi-Gao Xiang, Kai Shu et al.· Biochimica et biophysica act...· 0 citations
This review details the role of tumor derived exosomes in shaping an immunosuppressive TME, especially their capacity to modulate T-cell function, polarize myeloid cells, and influence immune checkpoint signalling, and discusses emerging therapeutic strategies aimed at intercepting or reprogramming exosomal cargo.
RamaRao Malla, G. Nagaraju· Biochemical Pharmacology· 0 citations
Malignant progression and limited therapeutic response in gastric cancer (GC) cannot be explained solely by increased proliferation or oncogenic alterations. Instead, they reflect how tumor cells regulate their death threshold under sustained damage, metabolic stress and immune pressure. Evidence indicates that GC cell...
Meng-Ru Liu, Zhu-Jun Wu, Qiao Chen et al.· International Journal of Mol...· 0 citations
This review systematically elaborates on the central role of "tumor-host" metabolic crosstalk in reshaping both the TME and the broader host macroenvironment, suggesting the need for multiscale metabolic interventions to improve cancer treatment efficacy.
Yi Zhang, Caixia Suo, Linchong Sun· Chinese Medical Journal· 0 citations
Current evidence linking stemness plasticity to spatial niche regulation and treatment failure in HCC is synthesized, and a therapeutic framework that integrates targeting of intracellular regulatory programs with disruption of microenvironmental support systems is outlined.
H. Ahn, Sujin Kim, H. Cho· Journal of Liver Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.